COPY-NUMBER SIGNATURES AND MUTATIONAL PROCESSES IN HIGH GRADE SEROUS OVARIAN CARCINOMA

被引：0

作者：

Macintyre, Geoff ^{[1
]}

Goranova, Teodora E. ^{[1
]}

De Silva, Dilrini ^{[1
]}

Ennis, Darren ^{[2
]}

Piskorz, Anna M. ^{[1
]}

Eldridge, Matthew ^{[1
]}

Sie, Daoud ^{[3
]}

Lewsley, Liz-Anne ^{[4
]}

Hanif, Aishah ^{[4
]}

Wilson, Cheryl ^{[4
]}

Dowson, Suzanne ^{[2
]}

Glasspool, Rosalind M. ^{[5
]}

Lockley, Michelle ^{[6
,7
]}

Brockbank, Elly ^{[8
]}

Montes, Ana ^{[9
]}

Walther, Axel ^{[10
]}

Sundar, Sudha ^{[11
]}

Edmondson, Richard ^{[12
,13
]}

Hall, Geoff D. ^{[14
]}

Clamp, Andrew ^{[15
]}

Gourley, Charlie ^{[16
]}

Hall, Marcia ^{[17
]}

Fotopoulou, Christina ^{[18
]}

Gabra, Hani ^{[18
,19
]}

Paul, James ^{[4
]}

Supernat, Anna ^{[1
]}

Millan, David ^{[20
]}

Hoyle, Aoisha ^{[20
]}

Bryson, Gareth ^{[20
]}

Nourse, Craig ^{[2
]}

Mincarelli, Laura ^{[2
]}

Sanchez, Luis Navarro ^{[2
]}

Ylstra, Bauke ^{[3
]}

Jimenez-Linan, Mercedes ^{[21
,22
]}

Moore, Luiza ^{[21
,22
]}

Hofmann, Oliver ^{[2
,23
]}

Markowetz, Florian ^{[1
]}

McNeish, Iain A. ^{[2
,5
,18
]}

Brenton, James D. ^{[1
,21
,22
,24
]}

机构：

[1] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England

[2] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland

[3] Vrije Univ Amsterdam Med Ctr, NL-1007 MB Amsterdam, Netherlands

[4] Univ Glasgow, Inst Canc Sci, Canc Res UK Clin Trials Unit, Glasgow G12 0YN, Lanark, Scotland

[5] Beatson West Scotland Canc Ctr, Glasgow G12 0YN, Lanark, Scotland

[6] Queen Mary Univ London, Barts Canc Inst, London EC1M 6BQ, England

[7] Univ Coll London Hosp, London WC1E 6BD, England

[8] Barts Hlth NHS Trust, London E1 1BB, England

[9] Guys Hosp, London SE1 9RT, England

[10] Bristol Canc Inst, Bristol BS2 8ED, Avon, England

[11] City Hosp, Birmingham B18 7QH, W Midlands, England

[12] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England

[13] St Marys Hosp, Manchester, Lancs, England

[14] Manchester Acad Hlth Sci Ctr, Dept Obstet & Gynaecol, Manchester, Lancs, England

[15] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England

[16] Level 5,Oxford Rd, Manchester, Lancs, England

[17] St Jamess Inst Oncol, Leeds LS9 7TF, W Yorkshire, England

[18] Christie Hosp, Manchester M20 4BX, Lancs, England

[19] Univ Edinburgh, MRC IGMM, Nicola Murray Ctr Ovarian Canc Res, Edinburgh EH4 2XR, Midlothian, Scotland

[20] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England

[21] Imperial Coll, Div Canc, London W12 0NN, England

[22] Imperial Coll, Dept Surg & Canc, Ovarian Canc Act Res Ctr, London W12 0NN, England

[23] Imperial Coll, London W12 0NN, England

[24] AstraZeneca, IMED Biotech Unit, Early Clin Dev, Cambridge, England

来源：

CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：64 / 64

页数：1

共 50 条

[21] Copy number variation status of DNA in extracellular vesicles as novel biomarkers of high-grade serous ovarian carcinoma
Uekusa, Ryosuke
Yokoi, Akira
Yoshida, Kosuke
Matsuazki, Juntaro
Yamamoto, Yusuke
Kajiyama, Hiroaki
CANCER RESEARCH, 2024, 84 (06)
[22] Predictive Modeling Using a Somatic Mutational Profile in Ovarian High Grade Serous Carcinoma
Sohn, Insuk
Sung, Chang Ohk
PLOS ONE, 2013, 8 (01):
[23] Methylomic Signatures of High Grade Serous Ovarian Cancer
Cardenas, Horacio
Fang, Fang
Jiang, Guanglong
Perkins, Susan M.
Zhang, Chi
Emerson, Robert E.
Hutchins, George
Keer, Harold N.
Liu, Yunlong
Matei, Daniela
Nephew, Kenneth
EPIGENETICS, 2021, 16 (11) : 1201 - 1216
[24] Evolutionary characterization and refinement of copy-number high endometrial carcinoma
Kramer, Claire J.
Ruano, Dina
Hawari, Aliah
Blanc-Durand, Felix
de Kroon, Cor D.
Kroep, Judith R.
Ortoft, Gitte
Hogdall, Estrid
Leary, Alexandra
Creutzberg, Carien L.
Vreeswijk, Maaike P.
Horeweg, Nanda
Church, David N.
Wedge, David C.
Bosse, Tjalling
CANCER RESEARCH, 2024, 84 (06)
[25] Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Zhao, Siming
Choi, Murim
Overton, John D.
Bellone, Stefania
Roque, Dana M.
Cocco, Emiliano
Guzzo, Federica
English, Diana P.
Varughese, Joyce
Gasparrini, Sara
Bortolomai, Ileana
Buza, Natalia
Hui, Pei
Abu-Khalaf, Maysa
Ravaggi, Antonella
Bignotti, Eliana
Bandiera, Elisabetta
Romani, Chiara
Todeschini, Paola
Tassi, Renata
Zanotti, Laura
Carrara, Luisa
Pecorelli, Sergio
Silasi, Dan-Arin
Ratner, Elena
Azodi, Masoud
Schwartz, Peter E.
Rutherford, Thomas J.
Stiegler, Amy L.
Mane, Shrikant
Boggon, Titus J.
Schlessinger, Joseph
Lifton, Richard P.
Santin, Alessandro D.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (08) : 2916 - 2921
[26] Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma
Nguyen, Mai T. N.
Rajavuori, Anna
Huhtinen, Kaisa
Hietanen, Sakari
Hynninen, Johanna
Oikkonen, Jaana
Hautaniemi, Sampsa
BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
[27] Single-cell analysis of copy-number alterations in serous ovarian cancer reveals substantial heterogeneity in both low- and high-grade tumors
Kumar, Manonmani
Bowers, Robert R.
Delaney, Joe R.
CELL CYCLE, 2020, 19 (22) : 3154 - 3166
[28] The role of different TGFβ signatures in predicting outcome in high grade serous ovarian carcinoma.
Mahdi, Haider
Rose, Peter Graham
Abdul-Karim, Fadi W.
Monk, Bradley J.
Ni, Ying
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[29] Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
Vescio, Martina
Paracchini, Lara
Beltrame, Luca
D'Incalci, Maurizio
Marchini, Sergio
Pattini, Linda
ADVANCES IN CANCER BIOLOGY-METASTASIS, 2023, 7
[30] Mutational and selective effects on copy-number variants in the human genome
Cooper, Gregory M.
Nickerson, Deborah A.
Eichler, Evan E.
NATURE GENETICS, 2007, 39 (Suppl 7) : S22 - S29

← 1 2 3 4 5 →